Learn how frameworks like Solid, Svelte, and Angular are using the Signals pattern to deliver reactive state without the ...

Your trading bot crashes at 3 AM because the forex feed went silent. Real-time currency data really shouldn't mean spe ...

Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Small Cap Growth Virtual Investor Conference, held ...

While most AI tools focus on answers, summaries, and suggestions, ConscioussAI is built around a more practical goal: helping ...

Exploratory analysis from Phase 1b/2 breast cancer trial reinforces CD47 as a predictive biomarker for response, as previously observed in the ASPEN-06 trial in HER2-positive gastric cancer – ...

Hunter syndrome (MPS II) presentations will include analysis from continued follow-up of Phase 1/2 data for tividenofusp alfa (DNL310), currently under FDA Priority Review Preliminary data from Phase ...

ULTIMATE I & II are two randomized, double-blind, double-dummy, parallel group, active comparator-controlled clinical trials of identical design, in patients with RMS treated for 96 weeks. Patients ...

Following the presentations, the data presented will be available on the Publications page, located within the Pipeline section, of the Company's website at . ULTIMATE I & II are two randomized, ...

NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI ® (ublituximab-xiiy), to be presented at ...

Following the presentations, the data presented will be available on the Publications page, located within the Pipeline section, of the Company’s website at www ...

Artiva Biotherapeutics is working on NK cell-based immunotherapy to treat autoimmune disease. Their lead project is an unmodified, preserved NK product that seeks to address challenges posed for CAR T ...